BIO-NIVESH Platform

-NIVESH Platform

Context

The Union Minister of State (Independent Charge) for Science & Technology recently launched the BIO-NIVESH Platform to boost private investment in biotechnology innovations.

Key Features

  1. It is a platform that links biotechnology and deep-tech startups with investors, especially for technologies approaching scale-up and commercialisation.
  2. Organized by: It has been organized by BIRAC (Biotechnology Industry Research Assistance Council) under the Department of Biotechnology (DBT).
  3. Ministry Involved: It comes under the Ministry of Science & Technology.
  4. Selection Criteria: Focuses on innovation, market potential, scalability, development stage and regulatory readiness.
  5. Two-way Engagement: Helps startups understand investor needs and investors assess scientific and regulatory requirements.
  6. Recurring Initiative: Future editions will be held in different cities to strengthen regional biotech ecosystems.
  7. Inaugural Edition: Included 20 startups and around 50 investors.
  8. Focus Areas: Capital access, commercialisation and scale-up of biotechnology innovations.

 

Significance for Biotechnology Ecosystem

  1. Bridges the funding gap between research and commercialisation.
  1. Promotes the transition of innovations from research entrepreneurship industry market.
  1. Strengthens India’s biotechnology and deep-tech ecosystem through greater private investment.

 FAQs

Q1. What is the BIO-NIVESH Platform?
Ans: It is a platform that connects biotechnology startups with investors to facilitate private investment in innovations ready for scale-up and commercialisation.

Q2. What is the main objective of BIO-NIVESH?
Ans: Its key objective is to improve access to private capital for promising biotechnology innovations and help convert research into commercially viable products.

Q3. How is BIO-NIVESH different from a conventional investor-startup meeting?
Ans: It is designed as a two-way engagement platform, combining investor interaction with discussions on the scientific, regulatory and commercial challenges specific to biotechnology.